Purinergic signaling in bone

Robin M. H. Rumney, Ning Wang, Ankita Agrawal, Alison Gartland*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Purinergic signaling in bone was first proposed in the early 1990s with the observation that extracellular ATP could modulate events crucial to the normal functioning of bone cells. Since then the expression of nearly all the P2Y and P2X receptors by osteoblasts and osteoclasts has been reported, mediating multiple processes including cell proliferation, differentiation, function, and death. This review will highlight the most recent developments in the field of purinergic signaling in bone, with a special emphasis on recent work resulting from the European Framework 7 funded collaboration ATPBone, as well as Arthritis Research UK and Bone Research Society supported projects.

Original languageEnglish
Article number116
JournalFrontiers in Endocrinology
Volume3
DOIs
Publication statusPublished - 19 Sep 2012
Externally publishedYes

Keywords

  • ATP
  • bone
  • osteoblast
  • osteoclast
  • osteoporosis
  • P2x
  • P2y
  • purinergic signaling

Fingerprint

Dive into the research topics of 'Purinergic signaling in bone'. Together they form a unique fingerprint.

Cite this